

<!-- page 1 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
1A
w;s úfYI
wxl 1950$1 - 2016 ckjdß ui 18 jeks i÷od - 2016'01'18
No. 1950/1  -  MONDAY,  JANUARY  18,  2016
EXTRAORDINARY
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
The Gazette of the Democratic Socialist Republic of Sri Lanka
(Published by Authority)
PART I : SECTION (I) — GENERAL
Government  Notifications
This Gazette Extraordinary can be downloaded from www.documents.gov.lk
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  
CONVENSION   AGAINST  DOPING  IN   SPORT  ACT,   No. 33   OF  2013
REGULATIONS made by the Minister of  Sports under Section 34 read with Section 3 of the Convention against Doping in
Sport Act, No. 33 of 2013.
DAYASIRI JAYASEKARA,
Minister of Sports.
Colombo,
09th December, 2015.
Regulations
1. These regulations may be cited as the Anti-Doping (Prohibited List) Regulations  No. 02 of 2015.
2. These regulations shall be deemed to have come into  operation on  1
st, January 2016.
THE WORLD ANTI-DOPING CODE
THE 2016 PROHIBITED LIST
INTERNATIONAL    STANDARD
The Official text of the Prohibited List shall be maintained by WADA and shall be published in English and French.
In the event of any conflict between the English and French versions,  the English  version shall prevail.
This List shall come into effect on 01 st  January 2016.
The 2016 prohibited List
16th September 2015

<!-- page 2 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
2A
WORLD    ANTI-DOPING    CODE
INTERNATIONAL STANDARD
PROHIBITED    LIST  JANUARY 2016
This List shall come into effect on 01 st January 2016
In accordance with Article  4.2.2 of the World Anti-Doping Code, all Prohibited Substances shall  be considered  as
“Specified Substances” except Substances in classes S1, S2, S4.4,  S4.5, S6.a, and Prohibited Methods  M1, M2 and M3.
SUBSTANCES    AND    METHODS    PROHIBITED    AT    ALL   TIMES
(IN-AND  OUT-OF-COMPETITION)
PROHIBITED    SUBSTANCES
S0. NON-APPROVED   SUBSTANCES
Any pharmacological substance which is not addressed  by any of the subsequent sections of the List and with no current
approval by any governmental  regulatory health authority for human therapeutic use (e.g. drugs under pre-clinical or cinical
developement or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times.
S1.   ANABOLIC   AGENTS
Anabolic agents are prohibited.
1.Anabolic Androgenic Steroids (AAS)
a. Exogenous*  AAS,  including:
1- Androstenediol  
(5-androst-1-ene-3 17-diol); 1-androstenedione  (5-androst-1-ene-3, 17-dione); 1-Testosterone [ -
hydroxy-5-androst-1-en-3-one]: 4-Hydroxytestosterone[4, -dihydroxyandrost-4-en-3-one]19-Norandrostenedione[estr-4-
ene-3,17-dione]:  bolandiol  (estr-4-ene-317-diol); bolasterone ; boldenone; boldione  (androsta-1,4-diene-3 17-dione);
calusterone; clostebol; danazol ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17-ol); dehydrochlormethyltestosterone (4-chloro--
hydroxy- -methylandrosta-1,4-dien-3-one); desoxymethyltestosterone  ( -methyl-5 -androst-2-en- -ol); drostanolone  ;
ethylestrenol  (19-norpregna-4-en- -ol);  fluoxymesterone;  formebolone; furazabol  ( -methyl[1,2,5]oxadiazolo[3',4':2,3]-
5-androstan--ol); gestrinone; mestanolone, mesterolone, metandienone ; ( -hydroxy-17-methylandrosta-1,4-dien-3-one);
metenolone; methandriol; methasterone (-hydroxy-2,17-dimethyl-5-androstan-3-one); methyldienolone (-hydroxy-17-
methylestra-4,9-dien-3-one);  Methyl-1-testosterone ( -hydroxy-17,methyl-5-androst-1-en-3-one); methylnortestosterone  (-
hydroxy-17 -methylestr-4-en-3 one ; Methyltestosterone; metribolone  (methyltrienolone, -hydroxy-17 -methylestra-4,9,11-
trien-3-one); mibolerone;  nandrolone ; norboletone  norclostebol; norethandrolone; oxabolone; oxandrolone ; oxymesterone;
oxymetholone; prostanozol  ( -[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5 -androstane); quinbolone; stanozolol;
stenbolone; Tetrahydrogestrinone ( -hydroxy-18a-homo-19-nor-17 -pregna-4,9,11-trien-3-one); trenbolone  ( -hydroxyestr-
4,9,11-trien-3-one); and  other substances with a similar chemical structure or similar biological effect (s).
b. Endogenous** AAS when administered exogenously :
Androstenediol (androst-5-ene-317-diol);  Androstenedione, (androst-4-ene-3,17-dione);  dihydrotestosterone  (-hydroxy-
5-androstan-3-one);  prasterone  (dehydroepiandrosterone, DHEA,3 -hydroxyandrost-5-en-17-one);  testosterone ; and their
metabolites and  isomers, including but not limited to:
3-hydroxy-5 -androstan-17-one; 5-androstane- --diol; -androstane-3 ,17 -diol;  -androstane-3 ,17 -diol;
5-androstane- ,-diol; 5 -androstane- .-diol;- 7 -Hydroxy-DHEA; 7 -Hydroxy-DHEA; 4-androstendiol (androst-4-
ene-,-diol); 5-androstenedione (androst-5-ene-3, 17-dione) ; 7-keto-DHEA ; 19-Norandrosterone ; 19-Noretiocholanolone.
Androst-4-ene-3a,17-diol;Androst-4-ene-3a,17 -diol;Androst-4-ene-3,17-diol; Androst-5-ene-3a,17 -diol;Androst-5-ene-3a,17 -
diol;Androst-5-ene-3 ,17-diol;Androsteron: Epi-dihydrotestoterone Epitestasterone:Etiocholanolone.

<!-- page 3 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
3A
   2. OTHER   ANABOLIC   AGENTS
Including, but not limited to:
Clenbuterol, selective androgen receptor modulators (SARMs; e.g. andarine and ostarine), tibolone, zeranol and zilpaterol.
For purposes of this section:
* “exogenous” refers to a substance which is not ordinarily  produced by the body naturally.
** “endogenous” refers to a substance which is  ordinarily  produced by the body naturally.
S2. PEPTIDE  HORMONES,   GROWTH     FACTORS,   RELATED    SUBSTANCES   AND   MIMETICS
The following substances, and other substances with similar chemical structure or similar  biological effect(s), are
prohibited:
1. Erythropoietin - Receptor agonists:
1.1 Erythropoiesis-Stimulating Agents (ESAs)  including e.g. darbepoietin (dEPO);  erythropoietins (EPO) ;
EPO-Fc; EPO mimetic peptides  (EMP), e.g. CNTO 530 and peginesatide; methoxy polyethylene glycol-
epoetin beta  (CERA).
1.2 Non - erythropoietic EPO - Receptor agonists,  e.g. ARA - 290 ; asialo EPO; carbamylated EPO.
2. Hypoxia - inducible factor (HIF) stabilizers, e.g. cobalt and FG-4592; and HIF activators, e.g. argon, xenon;
3. Chorionic Gonadotrophin (CG) and Luteinizing  Hormone (LH) and their releasing factors, e.g. buserelin, gonadorelin
and Leuprorelin, in males;
4. Corticotrophins and their releasing factors, e. g. corticorelin ;
5. Growth Hormone  (GH) and its releasing factors including; Growth Hormone Releasing Hormone  (GHRH)
and its analogues , e.g. CJC-1295, sermorelin  and tesamorelin;  Growth Hormone Secretagogues  (GHS),
e.g. ghrelin and ghrelin mimetics,  e.g. anamorelin and ipamorelin;  GH - Releasing Peptides  (GHRPs), e.g.
alexamorelin,  GHRP - 6, hexarelin  and pralmorelin (GHRP - 2).
Additional prohibited growth factors ;
Fibroblast Growth Factors (FGFs); Hepatocyte Growth Factor (HGF); Insulin-like Growth Factor - 1 (IGF-1)  and
its analogues; Mechano Growth Factors (MGFs); Platelet-Derived Growth Factor (PDGF); Vascular-Endothelial
Growth Factor  (VEGF) and any other growth factor affecting muscle, tendon or ligament protein synthesis/
degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching.
S3. BETA - 2 AGONISTS
All beta - 2 agonists, including all optical isomers, e.g. d - and l- where relevant, are prohibited.
Except :
* Inhaled salbutamol (maximum 1600 micrograms over 24 hours) ;
* Inhaled formoterol (maximum delivered dose 54  micrograms over 24 hours); and
* Inhaled salmeterol  in accordance with the manufacturers’ recommended therapeutic regimen.
The presence in urine of salbutamol in excess of 1000 ng/ml or formoterol in excess of 40ng/ml is presumed not to be an
intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the
Athlete proves, through  a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of
the therapeutic inhaled dose up to the maximum indicated above.

<!-- page 4 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
4A
S4.   HORMONE   AND   METABOLIC   MODULATORS
The following hormone and metabolic modulators are prohibited:
1. Aromatase inhibitors including, but not limited to: aminoglutethimide; anastrozole; androsta - 1,4,6,-
triene-3,17-dione  (androstatrienedione); 4- androstene-3,6,17 trione  (6-oxo); exemestane; formestane;
letrozole;  testolactone .
2. Selective estrogen receptor modulators (SERMs) including, but not limited to : Raloxifene; Tamoxifen ;  Toremifene.
3. Other anti-estrogenic substances  including, but not limited to: clomiphene; cyclofenil and fulvestrant .
4. Agents modifying myostatin function (s)  including, but not limited, to : myostatin inhibitors .
5. Metabolic  modulators:
5.1 Activators of the AMP-activated protein kinase  (AMPK) e.g. AICAR; and Peroxisome Proliferator
Activated Receptor  (PPAR)  agonists, e.g. GW 1516;
5.2 Insulins and Insulin - Mimetics
5.3 Meldonium;
5.4 Trimetazidine.
S5. DIURETICS    AND   MASKING    AGENTS
The following  diuretics, and masking agents  are prohibited, as are other substances with a similar chemical structure
or similar biological effect (s)
Including, but not limited to:
Desmopressin; probenecid; plasma expanders , e.g. glycerol and intravenous administration of albumin,
dextran,  hydroxyethyl starch  and mannitol.
Acetazolamide; amiloride;  bumetanide; canrenone; chlortalidone;  etacrynic acid; furosemide;
indapamide; metolazone; spironolactone; thiazides,  e.g.  bendroflumethiazide, chlorothiazide and
hydrochlorothiazide; triamterene and vaptans, e.g. tolvaptan.
Except:
Drospirenone; pamabrom; and ophthalmic use of carbonic anhydrase inhibitors
e.g. dorzolamide, brinzolamide.
Local administration of felypressin in dental anaesthesia.
The detection in an Athlete’s Sample at all times or in -Competition, as aplicable, of any quantity of the following
substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine,
in conjunction with a diuretic or masking agent, will be considered as an Adverse Analytical Finding  unless the Athlete
has an approved TUE for that substance in addition to the one granted for the diuretic or masking agent.

<!-- page 5 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
5A
PROHIBITED   METHODS
M1.  MANIPULATION    OF    BLOOD   AND   BLOOD    COMPONENTS
The following  are prohibited:
1. The administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous
blood, or red blood cell products of any origin into the circulatory system.
2. Artificially enhancing the uptake, transport or delivey of  oxygen.
Including, but not limited to:
Perfluorochemicals; efaproxiral (RSR 13) and modified  haemoglobin products, e.g. haemoglobin-based blood
substitutes and microencapsulated haemoglobin  products, excluding supplemental oxygen.
3. Any form of intravascular manipulation of the blood or blood components by physical or chemical means.
M2.  CHEMICAL    AND   PHYSICAL    MANI PULATION
The following,  are prohibited:
1. Tampering, or Attempting to Tamper, to alter the integrity and  validity of Samples collected during Doping Control.
Including, but not limited to:
Urine substitution and/or adulteration, e.g. proteases.
2. Intravenous infusions and /or injections of more than 50ml  per 6 hour period except for those legitimately received
in the course of hospital admissions, surgical procedures or clinical investigations.
M3.  GENE    DOPING
The following with the potential to enhance sport performance, are prohibited:
1. The transfer of ploymers of nucleic acids  or nucleic acid analogues;
2. The use of normal or genetically modified cells.
SUBSTANCES   AND    METHODS
PROHIBITED IN- COMPETITION
In addition to the categories S0 to S5 and M1 to M3 defined above,
the following categories are prohibited in - Competition:
PROHIBITED    SUBSTANCES
S6. STIMULANTS
All stimulants, including all optical isomers, e.g. d- and l- where relevant, are prohibited.
Stimulants include:
(a) Non- Specified Stimulants:

<!-- page 6 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
6A
Adrafinil; amfepramone; amfetamine; amfetaminil; amiphenazole; benfluorex; benzylpiperazine; bromantan; clobenzorex;
cocaine; cropropamide; crotetamide; fencamine; fenetylline; fenfluramine; fenproporex; fonturacetam [4- phenylpiracetam
(carphedon)] ; furfenorex; mefenorex; mephentermine; mesocarb; metamfetamine ( d-) p- methylamphetamine; modafinil;
norfenfluramine; phendimetrazine; phentermine; prenylamine and prolintane.
A stimulant not expressly  listed in this section is a Specified Substance.
b. Specified Stimulants.
Including, but not limited to:
Benzfetamine; cathine**; cathinone and its analogues, e.g. mephedrone, methedrone, and   -pyrrolidinovalerophenone;
dimethylamphetamine; ephedrine ***; epinephrine**** (adrenaline); etamivan; etilamfetamine;  etilefrine; famprofazone;
fenbutrazate; fencamfamin; heptaminol; hydroxyamfetamine (parahydroxyamphetamine); isometheptene; levmetamfetamine;
meclofenoxate; methylenedioxymethamphetamine; methylephedrine***;  methylhexaneamine; (dimethylpentylamine);
methylphenidate; nikethamide, norfenefrine; octopamine; oxilofrine (methylsynephrine) pemoline; pentetrazol;
phenethylamine and its derivatives; phenmetrazine; phenpromethamine; propylhexedrine;   pseudoephedrine*****;
selegiline; sibutramine; strychnine; tenamfetamine (methylenedioxyamphetamine), tuaminoheptane;  and other substances
with a similar chemical structure or similar biological effect(s).
Except:
clonidine
Imidazole derivatives for topical/ophthalmic use and those stimulats included in the 2016 monitoring Program*.
* Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, and synephrine; These substances
are included in the 2016 monitoring Program, and are not considered Prohibited Substances .
** Cathine: Prohibited when its concentration in urine is greater than 5 micrograms per milliliter.
*** Ephedrine and methylephedrine:  Prohibited when the concentration of either in urine is greater than 10  micrograms
per milliliter.
**** Epinephrine (adrenaline): Not prohibited in local administration, e.g. nasal, ophthalmologic, or co-administration
with local anaesthetic agents.
***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per milliliter.
S7. NARCOTICS
Prohibited:
Buprenorphine; dextromoramide;  diamorphine (heroin); fentanyl and its derivatives; hydromorphone; methadone;
morphine; oxycodone; oxymorphone; pentazocine;  pethidine.
S8. CANNABINOIDS
Prohibited:
natural, e.g. cannabis, hashish and marijuana, or synthetic
9- tetrahydrocannabinol (THC).
Cannabimimetics, e.g. “Spice”, JWH-018, JWH-073, HU-210.
S9. GLUCOCORTICOIDS


<!-- page 7 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
7A
All glucocorticoids are prohibited when administred by oral, intravenous, intramuscular or rectal routes.
SUBSTANCES   PROHIBITED   IN ; PARTICULAR     SPORTS
P1. ALCOHOL
Alcohol (ethanol) is prohibited  In-Competition only, in the following sports, Detection will be conducted by analysis
of breath and /or blood. The doping violation threshold is equivalent to a blood alcohol concentration of 0.10g/L.
Air Sports (FAI) Powerboating (UIM)
Archery (WA)
Automobile (FIA)
P2. BETA - BLOCKERS
Beta-blockers are prohibited  In-Competition only, in the following sports, and also prohibited Out-of-Competition where
indicated.
Archery (WA)*
Automobile (FIA)
Billiards (all disciplines) (WCBS)
Darts (WDF)
Golf (IGF)
Shooting (ISSF, IPC)*
Skiing/Snowboarding (FIS) in ski Jumping, Freestyle aerials/halfpipe and snowboard halfpipe/big air.
Underwater sports (CMAS) in constant-weight apnoea with or without fins, dynamic apnoea with and without
fins, free immersion apnoea, Jump Blue apnoea, spearfishing, static apnoea, target shooting and variable weight
apnoea.
* Also proibited Out-of-Competition
Including, but not limited to :
Acebutolol; alprenolol; atenolol; betaxolol; bisoprolol; bunolol; carteolol; carvedilol; celiprolol; esmolol; labetalol;
levobunolol; metipranolol; metoprolol; nadolol; oxprenolol; pindolol; propranolol; sotalol  timolol.
MONITORING   PROGRAM
* Meldonium was removed from the Monitoring Program and added to the Prohibited List.
* Hydrocodone, morphine/codeine ratio and tapentadol were removed from the Monitoring Program.
 2016 Prohibited List
Summary of Major Modifications and Explanatory Notes :
Substances and Methods Prohibited at all times (in-and out-of- comeptition)
Prohibited Substances
S2 : Peptide hormones, Growth Factors, Related Substances and Mimetics
* Leuprorelin replaced triptorelin as a more universal example of a chorionic gonadotrophin and luteinizing
hormone - releasing factor :
S4 : Hormone and Metabolic Modulators
* Insulin-mimetics were added to the list to include all insulin-receptor agonists
* Meldonium (Mildronate) was added because of evidence of its use by athletes with the intention of
enhancing performance

<!-- page 8 -->

I fldgi ( ^ I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2016'01'18
PART I : SEC. (I) - GAZETTE EXTRAORDINARY OF THE  DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 18.01.2016
8A
S5 : Diuretics and Masking Agents
* It was clarified that the ophthalmic use of carbonic anhydrase inhibitors is permitted.
Substances and Methods Prohibited in-competition
S6 : Stimulants :
* Its was clarified that clonidine is permitted
Substances prohibited in particular sports
PI : Alcohol :
* After consideration of the Federation International de Motocyclisme (FIM)’s request, their Federation was
removed from the list of sports prohibiting alcohol as a doping agent.
W ADA understands that FIM will address the use of alcohol using their own regulations.
02 - 2
PRINTED AT THE DEPARTMENT OF GOVERNMENT PRINTING, SRI LANKA.